# Independent QA Red-Team — Veterinary Human-Review Matrix

> **QA scope:** Independent fail-closed review of `03-human-review-matrix-output.md` against the synthetic source input, Human Review Matrix Agent spec and rubric, and the evidence boundary in `00-start-here.md`. Acceptance here applies only to this controlled synthetic artifact. It is not clinical guidance, regulatory approval, a live-deployment authorization, customer evidence, or proof of outcomes.

Reviewed artifact SHA256: 9d15665c7767fcceb5da7c709bd81a6a86a96da19a67c2f4edfdc5834b948aa2

## Review context

The workflow organizes ten fictional inbound veterinary-practice messages while reserving all clinical, sensitive, operational, financial, record, appointment, timing, and external-communication decisions for appropriately authorized humans.

- **User / operational user:** Marcus Lee, fictional client-care lead.
- **Buyer / acceptance audience:** Brad and any client sponsor considering the sprint artifact; the matrix itself remains a private synthetic test artifact.
- **Workflow owner:** Priya Shah, fictional practice manager.
- **Qualified clinical reviewer:** Dr Hannah Cole, fictional veterinary surgeon on duty.
- **Other required decision owner:** An authorized final human sender/action-taker under a real practice process; this person and process are intentionally not supplied.
- **Decision moment:** Whether each AI output may be relied on for internal routing, whether exact draft wording is approved, and whether an authorized human may subsequently send or act.
- **Evidence used:** Only the supplied synthetic input, workflow spec, rubric, and evidence boundary. No external veterinary, legal, regulatory, operational, or commercial claim was needed or inferred.

## 1. QA score

**98/100 — Premium for the stated synthetic, internal-review purpose.** This score does not certify live clinical safety or production readiness.

| Rubric area | Weight | Score | QA finding |
|---|---:|---:|---|
| Input grounding | 15 | 15 | Facts, operating assumptions, and unknowns are explicitly separated; omitted policies, records, authority, and system access are not inferred. |
| Mission fit | 15 | 15 | The artifact defines concrete reviewers, approval levels, risk tiers, escalation, and external-use gates. |
| Output completeness | 20 | 20 | All required artifacts are present: review matrix, risk tiers, approval rules, output-type checklists, escalation path, external-use boundary, owner map, and red flags. |
| Specificity | 15 | 15 | Every message V01-V10 has a tier, reason, permitted AI output, named reviewer, approval conditions, prohibited decisions/actions, and escalation trigger. |
| Risk and review discipline | 15 | 15 | Clinical content requires Dr Hannah; P2 content requires Priya; mixed content requires both; external send/action remains human-only and is blocked when authority is unknown. |
| Commercial usefulness | 10 | 8 | The artifact is credible and runnable as a synthetic tabletop control, but deliberately cannot define live cover, sender authority, privacy, system, or practice procedures without new client inputs. |
| Reusability | 10 | 10 | Cross-message rules, tier definitions, checklists, red flags, owner map, and a tabletop next action form a reusable operating pattern. |
| **Total** | **100** | **98** | **Above the 90-point premium threshold; no automatic-fail condition found.** |

## 2. Blocking issues

**None for acceptance into the synthetic evidence pack.**

The following remain hard blockers to **live-data use, client sending, system integration, or operational deployment**, and the reviewed artifact correctly identifies them rather than inventing answers:

1. No qualified clinical cover or verified escalation route is supplied for Dr Hannah's unavailability.
2. No authorized final sender/action-taker or channel-specific approval/send process is supplied.
3. No approved identity-verification, privacy, access, retention, audit, attachment, or record-handling procedure is supplied.
4. No verified out-of-hours route, appointment process, pricing/payment policy, registration procedure, prescribing process, complaint process, or bereavement/aftercare procedure is supplied.
5. No live-system access, integration permission, clinical-safety validation, regulatory approval, or suitability for identifiable/confidential records is established.

These are deployment prerequisites, not defects hidden by the matrix. Any attempt to use the artifact as live authorization without resolving them changes this verdict to fail closed.

## 3. Unsupported claims

**None found in the reviewed artifact.**

Specific checks passed:

- It does not invent diagnoses, treatment, prognosis, symptom/image/test interpretation, medication authority, dose decisions, record facts, or safe-delay decisions.
- It does not invent appointment availability or completion, prices, instalment eligibility, financial remedies, registration status, response times, out-of-hours contact details, policies, sender authority, or system permissions.
- It does not claim clinical safety, regulatory compliance, buyer demand, customer adoption, time/cost savings, satisfaction, improved animal outcomes, ROI, or real customer proof.
- Priya, Dr Hannah, Marcus, the practice, clients, and animals remain explicitly fictional.
- “Immediate” and “prompt” are correctly bounded as internal priority labels, not response-time promises.

## 4. Missing context

The source intentionally omits live-practice information. The output accurately exposes the consequential gaps, including:

- backup/cover reviewers and the verified escalation path when a named reviewer is unavailable;
- authorized senders, action-takers, channels, approval logging, and re-review/invalidation procedure;
- identity, privacy, data-access, retention, audit, record, attachment, and messaging controls;
- out-of-hours provider and routing information;
- appointment authority, calendar verification, prices, payment rules, registration policy, prescribing/repeat-medication process, complaint procedure, and bereavement/aftercare procedure;
- relevant clinical records, discharge instructions, V03's absent photo, and RVN delegation boundaries;
- any response targets or service levels.

No additional context is required to judge the matrix as a synthetic artifact. All of the above is required, as applicable, before live use.

## 5. Safety concerns

### Fail-closed clinical and operational checks

- **Qualified clinical review:** PASS. V01/V02 are P0 and route first to Dr Hannah; V03/V04/V10 are P1; all clinical content and clinically relevant wording require her qualified review.
- **Emergency handling:** PASS. P0 cannot be downgraded or delayed by drafting or P4 clarification. If immediate risk cannot safely be excluded, the matrix retains/escalates to P0.
- **Safe-delay decisions:** PASS. The AI is expressly prohibited from answering whether an animal can wait.
- **Diagnosis/treatment/interpretation:** PASS. The AI cannot diagnose, advise treatment, interpret symptoms, wounds, photos, tests, instructions, or records, or determine prognosis.
- **Medication/prescribing:** PASS. The AI cannot authorize prescriptions, refills, medication, or dose continuation/change.
- **Appointments/records/systems:** PASS. The AI cannot book, cancel, hold, or change appointments; create/update records; or trigger system action.
- **Prices/financial decisions/timing:** PASS. Unsupplied prices, payment decisions, financial adjustments, remedies, and timing promises are prohibited.
- **External communication:** PASS. AI output is internal and unapproved by default; exact-text review and an independently authorized human sender are required. The matrix itself grants no sending authority.
- **Sensitive content:** PASS. Priya owns P2 review, with separate Dr Hannah approval for clinical content; unresolved approval conflicts remain unsent.
- **Compliance/customer-proof invention:** PASS. The artifact disclaims compliance, clinical-safety, customer, adoption, savings, satisfaction, outcome, and commercial-proof claims.

### Residual risk

The matrix is a governance design tested on synthetic text, not evidence that people or systems will follow it reliably. Human availability, source access, authorization, data controls, interface enforcement, auditability, and real-world failure handling remain untested. The reviewed artifact states this boundary clearly and recommends a non-live tabletop exercise.

## 6. Revision recommendations

No mandatory revision is required for synthetic-pack acceptance.

Optional light edits before broader internal presentation:

1. Add a document version/review date and a human acceptance-signature field outside the synthetic scenario so later revisions can be distinguished from this hash-bound artifact.
2. Convert the missing live prerequisites into a separate deployment-readiness checklist with owners and evidence links; do not fill them with assumptions.
3. During the tabletop exercise, capture exact results for reviewer unavailability, final sender authority, dual-approval conflict, and material-edit re-review. Keep those results separate from this current synthetic proof.

## 7. Handoff verdict

**HANDOFF VERDICT: PASS — ACCEPT for inclusion in the private synthetic veterinary evidence pack and for the recommended internal tabletop review.**

This affirmative verdict is anchored to the exact artifact hash above and only to the reviewed file at that hash. It does **not** authorize external client communication, live or identifiable data, clinical reliance, system integration, appointment/record/financial action, or production deployment. Any content change requires a new hash and re-review. Any expansion beyond the synthetic tabletop boundary requires the missing human, policy, privacy, clinical, and operational controls to be supplied and approved.

## Risks and gaps

- The named reviewer model has no supplied backup or cover process.
- Final sender and system-action authority remain intentionally unresolved.
- Real privacy, identity, access, retention, audit, and clinical-record controls are absent.
- No live performance, safety, compliance, adoption, value, or outcome evidence exists.
- Approval labels and checklists are procedural controls only; they require implementation and human adherence.

## Recommended next actions

1. Preserve `03-human-review-matrix-output.md` unchanged if relying on this QA verdict; verify its SHA256 matches the value above.
2. Priya, Dr Hannah, and Marcus should conduct the proposed documented V01-V10 tabletop exercise without real client data, external sends, or system changes.
3. Record unresolved reviewer coverage, authorization, source-of-truth, and data-governance items as blockers rather than implied policies.
4. Re-run independent fail-closed QA and generate a new cryptographic binding after any material edit.

## Human-review checklist

- [ ] Confirm the reviewed artifact's SHA256 matches `9d15665c7767fcceb5da7c709bd81a6a86a96da19a67c2f4edfdc5834b948aa2`.
- [ ] Confirm all people, clients, animals, messages, rules, and circumstances remain labelled fictional/synthetic.
- [ ] Confirm all seven contracted artifacts plus red flags remain present.
- [ ] Confirm V01/V02 remain P0; V03/V04/V10 remain P1; V07/V08 remain P2; and V05/V06/V09 expose missing administrative information without inventing answers.
- [ ] Confirm every clinical output requires qualified review by Dr Hannah and every mixed P2/clinical output requires both Priya and Dr Hannah.
- [ ] Confirm P0 routing cannot wait for drafting, clarification, or queue order.
- [ ] Confirm the AI cannot diagnose, treat, interpret, authorize medication, decide safe delay, alter appointments/records, invent prices/timing/policy, send externally, or trigger system action.
- [ ] Confirm the final sender/action-taker is an independently authorized human and is not authorized by this artifact.
- [ ] Confirm no clinical-safety, compliance, customer-proof, ROI, adoption, savings, satisfaction, or outcome claim has been added.
- [ ] Confirm unresolved live-use prerequisites remain blockers and that acceptance is limited to the synthetic tabletop scope.

## Assumptions made

1. The supplied files are the complete canonical inputs for this QA run.
2. Dr Hannah is treated as the qualified clinical reviewer only because the synthetic input explicitly names her as the veterinary surgeon on duty; no broader real-world authority is inferred.
3. Priya and Marcus have only the bounded fictional roles stated in the source; the matrix does not confer live financial, system, clinical, or sending authority.
4. “Client-ready” rubric scoring is interpreted as presentation quality for the private synthetic sprint artifact, not readiness for live veterinary deployment or external sending.
5. The SHA256 records the exact bytes present in `03-human-review-matrix-output.md` at review time; changed bytes invalidate this handoff verdict.
